This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nielsen, E. I.
Right arrow Articles by Sandström, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, E. I.
Right arrow Articles by Sandström, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2007, p. 128-136, Vol. 51, No. 1
0066-4804/07/$08.00+0     doi:10.1128/AAC.00604-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Semimechanistic Pharmacokinetic/Pharmacodynamic Model for Assessment of Activity of Antibacterial Agents from Time-Kill Curve Experiments{triangledown}

Elisabet I. Nielsen,1,2* Anders Viberg,1 Elisabeth Löwdin,3 Otto Cars,3 Mats O. Karlsson,1 and Marie Sandström1

Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden,1 Hospital Pharmacy, University Hospital, Uppsala, Sweden,2 Department of Infectious Diseases, University Hospital, Uppsala, Sweden3

Received 17 May 2006/ Returned for modification 20 August 2006/ Accepted 13 October 2006

Dosing of antibacterial agents is generally based on point estimates of the effect, even though bacteria exposed to antibiotics show complex kinetic behaviors. The use of the whole time course of the observed effects would be more advantageous. The aim of the present study was to develop a semimechanistic pharmacokinetic (PK)/pharmacodynamic (PD) model characterizing the events seen in a bacterial system when it is exposed to antibacterial agents with different mechanisms of action. Time-kill curve experiments were performed with a strain of Streptococcus pyogenes exposed to a wide range of concentrations of the following antibiotics: benzylpenicillin, cefuroxime, erythromycin, moxifloxacin, and vancomycin. Bacterial counts were monitored with frequent sampling during the experiment. A simultaneous fit of all data was accomplished. The degradation of the drugs was monitored and corrected for in the model, and a link model was used to account for an effect delay. In the final PK/PD model, the total bacterial population was divided into two subpopulations: one growing drug-susceptible population and one resting insusceptible population. The drug effect was included as an increase of the killing rate of bacteria in the susceptible state, according to a maximum-effect (Emax) model. An internal model validation showed that the model was robust and had good predictability. In conclusion, for all drugs, the final PK/PD model successfully described bacterial growth and killing kinetics when the bacteria were exposed to different antibiotic concentrations. The semimechanistic model that was developed might, after further refinement, serve as a tool for the development of optimal dosing strategies for antibacterial agents.


* Corresponding author. Mailing address: Division of Pharmacokinetics and Drug Therapy, Uppsala University, Box 591, SE-751 24 Uppsala, Sweden. Phone: 46-(0)18-4714418. Fax: 46-(0)18-4714003. E-mail: elisabet.nielsen{at}farmbio.uu.se.

{triangledown} Published ahead of print on 23 October 2006.


Antimicrobial Agents and Chemotherapy, January 2007, p. 128-136, Vol. 51, No. 1
0066-4804/07/$08.00+0     doi:10.1128/AAC.00604-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Schmidt, S., Rock, K., Sahre, M., Burkhardt, O., Brunner, M., Lobmeyer, M. T., Derendorf, H. (2008). Effect of Protein Binding on the Pharmacological Activity of Highly Bound Antibiotics. Antimicrob. Agents Chemother. 52: 3994-4000 [Abstract] [Full Text]  
  • Viberg, A., Cars, O., Karlsson, M. O., Jonsson, S. (2008). Estimation of Cefuroxime Dosage Using Pharmacodynamic Targets, MIC Distributions, and Minimization of a Risk Function. J Clin Pharmacol 48: 1270-1281 [Abstract] [Full Text]  
  • Venisse, N., Gregoire, N., Marliat, M., Couet, W. (2008). Mechanism-Based Pharmacokinetic-Pharmacodynamic Models of In Vitro Fungistatic and Fungicidal Effects against Candida albicans. Antimicrob. Agents Chemother. 52: 937-943 [Abstract] [Full Text]  
  • Tam, V. H., Schilling, A. N., Poole, K., Nikolaou, M. (2007). Mathematical modelling response of Pseudomonas aeruginosa to meropenem. J Antimicrob Chemother 60: 1302-1309 [Abstract] [Full Text]